Farran Investments has let the 142,386 sq ft Tetron142 warehouse in Swadlincote to Brunel Healthcare Manufacturing.
The international pharmaceutical manufacturer has signed a 15-year lease on the warehouse, which was recently comprehensively refurbished by Farran Investments
Tom Donnachie, senior asset manager at Farran Investments, said: “We are delighted to have let Tetron142 to Brunel Healthcare, providing them with a high quality HQ warehouse facility building to support their expansion in the area. The letting is a direct result of our capital investment to upgrade the building, and the strategy to enhance assets within our portfolio. We are delighted to support Brunel Healthcare’s expansion in the area and look forward to seeing them increase their UK growth in the coming years.”
John Hackett, CEO of Brunel Healthcare, added: “We’ve been manufacturing vitamins and health food supplements in the Swadlincote area since the late 1800’s. We have experienced rapid growth over the last 15 years, and the lease of Tetron142 is an important part of our next chapter, with increasing growth opportunities for us, both at home, and in international markets.”
John Sambrooks, partner at Garrison Real Estate, which alongside JLL and Savills advised Farran Investments on the deal, said: “Tetron142 is the perfect building for Brunel to accelerate their growth and expansion of their operations within Swadlincote. The building provides a modern and well specified building following the recent refurbishment. We are very pleased to have supported Farran Investments to secure a tenant on a long-term lease and we wish Brunel continued success with their future plans.”
Brunel Healthcare was represented by Tim Harries & Partners.
